E Fund Management (HK)’s Abivax ABVX Stock Holding History

E Fund Management (HK)’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.6K	Buy	177 +45	+34%	+$5.09K	0.01%	284
2026 Q1	$14.7K	Buy	+132	New	+$15.6K	0.01%	262

Other funds holding ABVX

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Jupiter Topco New York $245B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

E Fund Management (HK)'s ABVX Position: Q2 2026 in Review

E Fund Management (HK) increased its Abivax (ABVX) stake by 34% in Q2 2026, buying an estimated $5.09K and bringing the position to 177 shares worth $23.6K. The position accounts for 0.01% of the portfolio, ranked #284.

E Fund Management (HK) first reported a position in ABVX in Q1 2026 and has held it in 2 quarters since. 303 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

E Fund Management (HK) held 177 shares of Abivax worth $23.6K as of Q2 2026.
E Fund Management (HK) bought 45 Abivax shares in Q2 2026, an estimated $5.09K.
Abivax made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #284 holding.
E Fund Management (HK) first reported a position in Abivax in Q1 2026 and has held it in 2 quarters since.
303 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.